Pharmadrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled substances and natural medicines such as psychedelics, cannabis and naturally derived, approved drugs. The company owns 80 per cent of Pharmadrug Production GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics licence and German EuGMP (European Union good manufacturing practices) certification, allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the EU. The company also owns 100 per cent of Super Smart, a Dutch company building a modern adult-use psychedelic retail business with an elevated and educational focus. Pharmadrug recently acquired Sairiyo Therapeutics, a biotech company that specializes in researching and reformulating established natural medicines with a goal of bringing them through regulatory and research-driven clinical trials.